Chief Executive Officer
Alexandra Ellervik
Alexandra Ellervik has a M.Sc. in Molecular Biology and was awarded a PhD in neurophysiology in 2004 at Lund University. After two years as a postdoctoral fellow at the University of Zurich in Switzerland, she was employed within the private business as project manager, business developer and marketer and also elected as board member. Dr Ellervik is currently employed as project manager at RhoVac AB and joined Selcis BioPharma 2021.
Founder and Board Member
Margareta Nyman
Margareta Nyman is Professor Emerita in Food Chemistry at the faculty of engineering in Lund. Her research is interdisciplinary and related to nutritional, chemical and engineering issues. The overall purpose of her research is related to food design for dietary prevention and has focused on dietary fibre/indigestible food components and their physico-chemical properties and how these properties can be related to nutritional effects, especially gastrointestinal health, colon short-chain fatty acid formation, bacterial gut metabolites and microbiota composition.
Founder and Board Member
Martin Johansson
PhD., Associate Professor in organic chemistry and M.Sc. chemical engineering at Lund University. He has nearly 20 years’ experience in medicinal chemistry and preclinical research and development. Currently he acting as Senior Director Medicinal Chemistry at Aqilion AB and Former Chief Scientific Officer at Respiratorius AB and Senior Research Scientist at AstraZeneca, Discovery R&D.
Chairman of the board
Christine Widstrand
Christine Widstrand is Executive Vice President at LU Holding AB and responsible for the Life Science Portfolio. She holds a PhD in Analytical Chemistry from Lund University. With a background at CEO and founder of several biotech companies, she has gained over twenty years of experience in business development, venture capital raising, international sales and marketing, licensing and organizational and quality management. Dr. Widstrand is certified as a board member by Styrelseakademin and has an extensive experience in board work, both as a member and as a chairman.
Board member
Gun-Britt Fransson
Gun-Britt Fransson has more than 30 years of experience in strategic management, research and development within the biotech, food and pharma industry. She has extensive experience of Board assignments and has acted as chairman and board member in both private enterprises, public companies, foundations and universities. Previous assignments include employment as VP research and development at Probi AB, CEO at Alligator Bioscience AB, research director at Orkla Foods A.S and various research managing positions at Procordia Food AB and KabiPharmacia AB.
Board member
Hanna Sjöström
Hanna Sjöström holds a Master of Business Administration and Technology Management from Lund University, and an Executive MBA in Leadership. She is also certified board member within Life Sciences. She has more than 15 years experience from international management roles at International companies, such as L’Oréal and The Coca-Cola Company, before joining the Life Science Industry as Marketing & Innovation Director for TePe. Hanna is CEO of Neola Medical AB (publ) since 2019.
Ulf Ellervik
Ulf Ellervik is Professor of Bioorganic Chemistry at Lund University. His research is focused on design and synthesis of carbohydrates to explore biological systems, with an emphasis on cell surface glycans. Apart from academic research, he has been involved in several other start-up companies, such as Gedea Biotech AB. He is also engaged in different aspects of science popularization, such as popular science books, articles and scientific TV-shows.
Founder
Carl-Magnus Andersson
Experienced drug discovery expert, brought one drug to the market
Founder
Olov Sterner
Prof. Sterner is an organic chemist that has devoted his life to the science of biologically active secondary metabolites. He was awarded the PhD degree in 1985, and after two years as a postdoctoral fellow at the University of Bonn in Germany he got a position as a researcher at Lund University. 1990 he became lecturer in organic chemistry, and 1999 Dr Sterner was appointed Professor at Lund University. His research efforts has resulted in > 430 scientific publications in international journals, 30 patents and patent applications, and several textbooks in organic chemistry and chemical toxicology. He has acted as Head of the Department of Chemistry (2006 -2012) and Dean of the Faculty of Science (2012 – 2018).
